Prevention Study in Adult Patients Suffering From Migraine Headaches

NCT00742209 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

526

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders
Migraine

Interventions

DRUG: GSK1838262
DRUG: Placebo

Sponsor

XenoPort, Inc.

Collaborators

[object Object]